Skip to main content

Table 2 Subgroup analysis based on clinical T stage

From: Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy

Subgroup

Postoperative features

PI-RADS (n = 201)

Non-PI-RADS (n = 179)

p

cT1-2

Pathological T stage

  

< 0.001

 pT2

143 (84.1)

110 (63.9)

 

 pT3-4

27 (15.9)

62 (36.1)

 

PSM

53 (31.2)

68 (39.5)

0.133

cT3

Pathological T stage

  

0.241

 pT2

15 (48.4)

1 (14.3)

 

 pT3-4

16 (51.6)

6 (85.7)

 

PSM

10 (32.2)

5 (71.4)

0.089

  1. Note—Unless otherwise indicated, data are number (percentages). PSM = positive surgical margin; PI-RADS = Prostate Imaging-Reporting and Data System